Spots Global Cancer Trial Database for childhood acute basophilic leukemia

Every month we try and update this database with for childhood acute basophilic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531	NCT01407757	Leukemia	DNA analysis gene expression... laboratory biom... pharmacogenomic...	- 29 Years	Children's Oncology Group
Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia	NCT00003758	Leukemia	cytarabine idarubicin allogeneic bone... autologous bone... peripheral bloo...	15 Years - 60 Years	National Cancer Institute (NCI)
Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia	NCT00006363	Adult Acute Bas... Adult Acute Eos... Adult Acute Ery... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Myelo... de Novo Myelody... Untreated Adult... Untreated Child...	cytarabine daunorubicin hy... etoposide valspodar filgrastim busulfan autologous hema... peripheral bloo... aldesleukin clinical observ... pharmacological...	15 Years - 59 Years	National Cancer Institute (NCI)
Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia	NCT01076569	Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Recurrent Child... Untreated Child...	laboratory biom...	- 21 Years	Children's Oncology Group
Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia	NCT00666588	Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Recurrent Adult... Recurrent Child... Secondary Acute...	idarubicin cytarabine bortezomib etoposide laboratory biom...	1 Year - 21 Years	National Cancer Institute (NCI)
Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia	NCT00372593	Leukemia	asparaginase cytarabine daunorubicin hy... etoposide gemtuzumab ozog... mitoxantrone hy...	- 29 Years	Children's Oncology Group
Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia	NCT00003758	Leukemia	cytarabine idarubicin allogeneic bone... autologous bone... peripheral bloo...	15 Years - 60 Years	National Cancer Institute (NCI)
Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia	NCT00006363	Adult Acute Bas... Adult Acute Eos... Adult Acute Ery... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Myelo... de Novo Myelody... Untreated Adult... Untreated Child...	cytarabine daunorubicin hy... etoposide valspodar filgrastim busulfan autologous hema... peripheral bloo... aldesleukin clinical observ... pharmacological...	15 Years - 59 Years	National Cancer Institute (NCI)
Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid Leukemia	NCT01438138	Leukemia	diagnostic labo...	- 21 Years	Children's Oncology Group
Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid Leukemia	NCT01438138	Leukemia	diagnostic labo...	- 21 Years	Children's Oncology Group
Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia	NCT01076569	Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Recurrent Child... Untreated Child...	laboratory biom...	- 21 Years	Children's Oncology Group

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: